TrialBMC complementary and alternative medicine2018

Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).

Carmen Tenorio-Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.